Skip to main content
. 2018 Nov 16;31(1):41–49. doi: 10.1016/j.jsha.2018.10.001

Table 3.

The RV echocardiographic characteristics of the studied groups.

Active Remission Control p-Value
Tricuspid E 0.49 ± 0.09 0.50 ± 0.07 0.50 ± 0.07 0.672
Tricuspid A 0.40 ± 0.07 0.39 ± 0.08 0.39 ± 0.09 0.476
Tricuspid E/è 4.33 ± 0.84 4.13 ± 0.83 4.50 ± 0.72 0.126
ESPAP 30.75 ± 4.79 29.85 ± 4.68 30.75 ± 4.98 0.594
TAPSE 19.10 ± 2.19 19.03 ± 2.38 19.58 ± 2.30 0.476
RVFAC 37.27 ± 2.81 36.33 ± 1.78 37.23 ± 1.72 0.106
MPI-TDI 0.42 ± 0.07 0.39 ± 0.04 0.41 ± 0.07 0.106
RV Global strain (%) −18.99 ± 1.58 −21.95 ± 1.69a −23.03 ± 2.02a <0.001 for active vs control and active vs remission and 0.031 for remission vs control

All data are represented as mean ± SD and number (percent).

a: significant with active group, b: significant with Remission group.

E: peak flow velocity during the early rapid filling phase; A: peak flow velocity during atrial contraction; E/è, the ratio of early flow velocity to the early annular velocity; ESPASP, estimated systolic pulmonary artery pressure TAPSE, tricuspid annular plane systolic excursion; RVFAC, right ventricular fractional area change; MPI, myocardial performance index; TDI, tissue Doppler imaging; RV, right ventricular; GLS, global longitudinal strain.